What is Medicus Pharma Ltd. Common Stock (MDCX)?

Medicus Pharma Ltd. Common Stock (MDCX) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of MDCX?

The current price of MDCX is $2.48. Prices are updated in real time on Stocks360.

What is MDCX's price-to-earnings (PE) ratio?

MDCX's trailing twelve-month PE ratio is -0.03, based on current price and earnings per share data available on Stocks360.

What is MDCX's market capitalization?

MDCX's market capitalization is $3,556,816.00, placing it in the small-cap tier.

Medicus Pharma Ltd. Common Stock (MDCX)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$2.48

Market Cap

$3.56M

PE (TTM)

-0.03

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.61

Day Range

$2.45 – $2.69

52-wk Range

$2.40 – $130.00

Avg Volume

N/A

Volume

19.37K

Medicus Pharma Ltd. Common Stock (MDCX) is a publicly traded company in the Healthcare sector. Latest price: $2.48. Market cap $3.56M. Trailing PE -0.03. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-29 · $115.00 2026-10-28 · $2.48 (-97.84%)

Earnings

Most Recent

Aug 12, 2026

EPS $-10.50 vs est. $-6.38

Missed by $4.13

Next Earnings

Nov 13, 2026

EPS estimate $-6.68

Proprietary Signals

Signal snapshot temporarily unavailable.

About Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.03×
P/S (TTM)	0.00×
P/B	-2.20×
PEG	0.00×
P/FCF (TTM)	-0.16×
EV / EBITDA	-0.21×
EV / Sales	0.00×
Earnings Yield	-1433.66%
Free Cash Flow Yield	-643.70%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$8.11M
Net Income (TTM)	-$50.99M
Free Cash Flow (TTM)	-$22.93M
Net Debt	$4.56M
Working Capital	$4.33M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	17867.26%
Return on Invested Capital	-269.16%